edetic acid has been researched along with Fungal Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diana, J; Gariazzo, MJ; Noirey, N; Persat, F; Picot, S; Schmitt, D; Vincent, C | 1 |
| Bahna, P; Hachem, R; Hanna, H; Raad, I; Stephens, LC | 1 |
2 other study(ies) available for edetic acid and Fungal Lung Diseases
| Article | Year |
|---|---|
Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity.
Topics: Aspergillosis; Aspergillus fumigatus; Cell Adhesion; Edetic Acid; Flow Cytometry; Galactose; Humans; Langerhans Cells; Lectins; Lung; Lung Diseases, Fungal; Mannans; Microscopy, Fluorescence; Monensin; Mucous Membrane; Phagocytosis; Protein Binding | 2003 |
EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcium; Colony Count, Microbial; Confidence Intervals; Creatinine; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edetic Acid; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Survival Analysis; Time Factors | 2006 |